Physician profile
Alois Binder
NPI 1235130931
$1,100.42
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $42.36 · 2021: $158 · 2022: $229 · 2023: $91.91 · 2024: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $447.26 | 2023-2024 | Na, Lcp, Va-Lcp |
| Stryker Corporation | $206.71 | 2019-2024 | Alphavent, T2 Alpha |
| Horizon Therapeutics Plc | $115.82 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.83 | 2021 | |
| Bioventus LLC | $44.23 | 2020-2024 | Durolane |
| Sanofi-Aventis U.S. LLC | $39.16 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $24.51 | 2021 | |
| Baudax Bio INC. | $24.47 | 2022 | |
| Ethicon US, LLC | $19.73 | 2021 | |
| Kci USA, INC. | $16.17 | 2020 | |
| Abbott Laboratories | $14.69 | 2019 | |
| Radius Health, INC. | $14.25 | 2019 | |
| Fidia Pharma USA INC. | $13.63 | 2022 | |
| Organogenesis INC. | $13.25 | 2021 | |
| Zyla Life Sciences, INC. | $12.92 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alois Binder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.